Clinic booking ≠ gene therapy screening.
Evaluating advanced therapy review pathways in China requires a review-ready medical dossier—not just a standard clinic booking. Missing pathology records, incomplete treatment history, or poorly translated genetic reports can stop institutional review before it begins. MedBridgeNZ organizes medical records and molecular reports for administrative review-readiness.




